TrialJournal of neuroinflammation2017

Safety and in vivo immune assessment of escalating doses of oral laquinimod in patients with RRMS.

Tjalf Ziemssen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.